Live Breaking News & Updates on Matthew korenberg

Stay informed with the latest breaking news from Matthew korenberg on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Matthew korenberg and stay connected to the pulse of your community

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2023 Earnings Call Transcript

Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.03, expectations were $0.58.

Boston , Massachusetts , United-states , China , Beijing , Japan , Tavo-espinoza , Amgen-kyprolis , Todd-davis , Paul-hadden , Matt-hewitt , Matthew-korenberg

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2023 Earnings Call Transcript

Operator: Thank you for standing by. My name is Danika and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Ligand Third Quarter 2023 Earnings Webcast.

Cambridge , Cambridgeshire , United-kingdom , Japan , New-york , United-states , China , Xintong , Guizhou , Beijing , Boston , Massachusetts

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2023 Earnings Call Transcript

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2023 Earnings Call Transcript November 8, 2023 Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.02, expectations were $0.68. Operator: Thank you for standing by. My name is Danika and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Ligand Third Quarter […]

Japan , New-york , United-states , China , Xintong , Guizhou , Beijing , Chinese , Primrose-bio , Amgen-kyprolis , Novan-sitavig , Matthew-korenberg

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2023 Earnings Call Transcript

Operator: Thank you for standing by. My name is Kyla Baker and I will be your conference operator today.

Boston , Massachusetts , United-states , California , Japan , Kansas , China , Beijing , Matt-korenberg , Orwin-asparaginase , Kyla-baker , Tavo-espinoza

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2022 Earnings Call Transcript

Operator: Good evening. My name is Rob and I will be your conference operator today. At this time, I would like to welcome everyone to the Ligand Pharmaceuticals Fourth Quarter 2022 Earnings Webcast.

China , Miami , Florida , United-states , California , Japan , Matt-hewitt , Joseph-pantginis , Simon-latimer , Larry-solow , Matt-korenberg , Todd-davis

Ligand Pharmaceuticals Incorporated (LGND) Q2 2021 Earnings Call Transcript

Operator
Good day and thank you for standing by. Welcome to the Ligand Pharmaceuticals Second Quarter Earnings Call. At this time all participants are in a listen-only mode. After the speaker's presentation there will be a question and answer session. [Operator Instructions]
I would now like to hand the conference over to your first speaker today the Head of Investor Relations, Mr. Simon Latimer. Please go ahead sir.
Simon Latimer --
Head of Investor Relations
Thank you. Welcome to Ligand's second quarter of 2021 financial results and business update conference call. Our speakers for today's call are in separate locations. Speaking today for Ligand will be John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO.

Emeryville , California , United-states , India , San-francisco-bay , China , Stanford-university , San-diego , San-francisco , Matt-hewitt , Joseph-pantginis , Jacob-johnson